Advanced Technology to Understand Immune Cell Behavior
Dynamic single-cell analysis instrument to evaluate immune cell function
This project is creating a new technology that uses advanced imaging and artificial intelligence to better understand how individual immune cells work and interact, which can help develop new treatments.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cellchorus INC. NIH-funded |
| Lab location | 1 site (Houston, UNITED STATES) |
| Project ID | NIH-11136848 on NIH RePORTER |
What this research studies
We are developing a new instrument called CellChorus® that uses a special imaging technique called Time-lapse Imaging Microscopy in Nanowell Grids (TIMING™) combined with artificial intelligence. This technology allows us to watch and analyze thousands of individual cells over time, including disease cells and immune cells, without destroying them. By tracking their movements, interactions, and overall performance, we can gain a much deeper understanding of how these 'living drugs' behave. This detailed insight is crucial for creating more effective cell-based therapies and identifying important signs of disease or treatment success.
Who could benefit from this research
Good fit: Patients who might benefit from advanced cell therapies, such as those for cancer or autoimmune diseases, could indirectly benefit from this research.
Not a fit: Patients not seeking or eligible for cell-based therapies would not directly benefit from this specific instrument development.
Why it matters
Potential benefit: If successful, this technology could lead to the development of more effective cell therapies and better ways to predict how patients will respond to treatments.
How similar studies have performed: The CellChorus platform has already been technically and commercially validated, suggesting a strong foundation for this advanced development.
Where this research is happening
Houston, UNITED STATES
- Cellchorus INC. — Houston, United States (Active)
Researchers
- Principal investigator: Cooper, Laurence J.n. — Cellchorus INC.
- Study coordinator: Cooper, Laurence J.n.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.